JP3008719B2 - Method for stabilizing a solution containing ascorbic acid and / or a salt thereof - Google Patents
Method for stabilizing a solution containing ascorbic acid and / or a salt thereofInfo
- Publication number
- JP3008719B2 JP3008719B2 JP5057880A JP5788093A JP3008719B2 JP 3008719 B2 JP3008719 B2 JP 3008719B2 JP 5057880 A JP5057880 A JP 5057880A JP 5788093 A JP5788093 A JP 5788093A JP 3008719 B2 JP3008719 B2 JP 3008719B2
- Authority
- JP
- Japan
- Prior art keywords
- pyrosulfite
- ascorbic acid
- solution
- salt
- iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、アスコルビン酸又は/
及びその塩を含む溶液の褐変化及び劣化を抑制する方法
と、該方法により安定化されたアスコルビン酸又は/及
びその塩を含む溶液を還元剤溶液として用いる、被検試
料中の鉄又は不飽和鉄結合能の測定方法に関する。The present invention relates to an ascorbic acid and / or
And a method for suppressing browning and deterioration of a solution containing a salt thereof and an iron or unsaturated metal in a test sample, wherein a solution containing ascorbic acid or / and a salt thereof stabilized by the method is used as a reducing agent solution. The present invention relates to a method for measuring iron binding ability.
【0002】[0002]
【従来の技術】アスコルビン酸又は/及びその塩は、抗
壊血病因子であることから、健康医薬品として古くから
利用されている。そして、最近ではアスコルビン酸又は
/及びその塩を配合した機能性食品や化粧品等が数多く
製造、販売され、その市場が拡大しつつある。しかしな
がら、アスコルビン酸は酸化され易く、また酸化される
と褐変してしまう性質を有し、食品や化粧品の分野に利
用するには問題が多い。2. Description of the Related Art Ascorbic acid and / or a salt thereof have been used for a long time as a health drug because they are anti-scurvy factors. Recently, a large number of functional foods and cosmetics containing ascorbic acid or / and salts thereof have been manufactured and sold, and the market is expanding. However, ascorbic acid is easily oxidized and has a property of browning when oxidized, so that there are many problems in using it in the fields of foods and cosmetics.
【0003】一方、臨床検査に於ける血清鉄又は不飽和
鉄結合能(UIBC)の測定は、鉄欠乏性貧血、再生不良性
貧血、悪性貧血、慢性出血性貧血、真性多血症、感染性
貧血等の各種貧血、急性肝炎、慢性肝炎、肝硬変等の肝
疾患の鑑別に重要な意味を持っており、臨床的意義が非
常に高い。血清中の鉄は、全て血清グロブリンの1つで
あるトランスフェリンと結合した形で存在するので、血
清鉄を測定する場合には、このトランスフェリンと鉄の
キレートを外し、遊離の鉄としてから鉄の測定を行う。
また、血清中のトランスフェリンはその1/3が鉄と結
合して存在するが、残り2/3は鉄と結合しない形で存
在し、その量は不飽和鉄結合能(UIBC)と呼ばれてい
る。不飽和鉄結合能の測定法としては、血清に既知量の
鉄を加え、トランスフェリンと結合させた残りの鉄の量
を測定して、鉄の減少量から不飽和鉄結合能を求める方
法が一般によく知られている。[0003] On the other hand, serum iron or unsaturated iron binding ability (UIBC) in clinical tests is measured by iron deficiency anemia, aplastic anemia, pernicious anemia, chronic hemorrhagic anemia, polycythemia vera, infectious It has an important significance in distinguishing various anemias such as anemia, liver diseases such as acute hepatitis, chronic hepatitis, and cirrhosis, and has a very high clinical significance. Since all iron in serum exists in a form bound to transferrin, which is one of serum globulin, when measuring serum iron, the chelate of transferrin and iron is removed, and iron is measured as free iron. I do.
In addition, transferrin in serum is present with one-third of it bound to iron, but the remaining two-thirds is in a form not bound to iron, and its amount is called unsaturated iron binding ability (UIBC). I have. As a method for measuring unsaturated iron binding ability, a method is generally used in which a known amount of iron is added to serum, the amount of remaining iron bound to transferrin is measured, and the unsaturated iron binding ability is determined from the reduced amount of iron. well known.
【0004】鉄の測定法としては、例えばα,α'-ジピ
リジル、o-フェナントロリン、バソフェナントロリン、
2,4,6-トリピリジル-S-トリアジン、3-(2-ピリジル)-5,
6ビス(4-スルホフェニル)-1,2,4-トリアジン等や、例え
ば 2-ニトロソ-5-(N-プロピル-N-スルホプロピル)アミ
ノフェノールに代表されるニトロソフェノール誘導体等
の鉄の発色剤を用いた比色分析法が一般的であるが、こ
れらは、全て二価の鉄の発色剤なので、使用に当たって
は三価の鉄を還元するための還元剤の併用を必要とす
る。三価の鉄の還元剤としては、L-アスコルビン酸,チ
オグリコール酸,塩酸ヒドロキシルアミン,ハイドロキ
ノン,ハイドロサルファイト,亜硫酸ナトリウム,硫酸
ヒドラジン,メタ重亜硫酸塩(ピロ亜硫酸塩)等が知ら
れているが、これらのうち精密分析用に十分その還元力
を発揮するのはL-アスコルビン酸とチオグリコール酸で
あるとされている。しかしながら、この2つの還元剤に
も実用上極めて重大な欠陥がある。つまり、チオグリコ
ール酸は、酸性側では溶液状態でも比較的安定で且つ還
元力も十分であるが、メルカプト基特有の悪臭があり、
使用上好ましからざるものである。一方アスコルビン酸
は、粉末での安定性は比較的良好であるが、溶液状態で
は安定性が極めて悪いという問題点がある。[0004] As a method for measuring iron, for example, α, α'-dipyridyl, o-phenanthroline, bathophenanthroline,
2,4,6-tripyridyl-S-triazine, 3- (2-pyridyl) -5,
Coloring of iron such as 6-bis (4-sulfophenyl) -1,2,4-triazine and nitrosophenol derivatives such as 2-nitroso-5- (N-propyl-N-sulfopropyl) aminophenol Although colorimetric analysis methods using agents are generally used, since these are all divalent iron color formers, their use requires the use of a reducing agent for reducing trivalent iron. Known trivalent iron reducing agents include L-ascorbic acid, thioglycolic acid, hydroxylamine hydrochloride, hydroquinone, hydrosulfite, sodium sulfite, hydrazine sulfate, metabisulfite (pyrosulfite) and the like. However, among these, L-ascorbic acid and thioglycolic acid are said to exhibit sufficient reducing power for precision analysis. However, these two reducing agents also have very serious defects in practical use. In other words, thioglycolic acid is relatively stable even in a solution state on the acidic side and has a sufficient reducing power, but has a malodor peculiar to a mercapto group,
It is not desirable for use. On the other hand, ascorbic acid has a problem that the stability in powder is relatively good, but the stability is extremely poor in a solution state.
【0005】アスコルビン酸を含有する溶液の安定化方
法としては、環状トリメタリン酸塩を共存させる方法
(特公昭59-32468)、dl-N-アセチルホモシステインチ
オラクトン(又はN-アセチル-L-システイン)と亜硫酸
塩を添加する方法(特開昭49-92219)等が提案されてい
る。これらの方法は、確かにアスコルビン酸溶液の安定
化効果が認められるものの、環状トリメタリン酸塩を共
存させる方法では、室温で4週間放置後のアスコルビン
酸の残存率は約80%に過ぎない。また、dl-N-アセチル
ホモシステインチオラクトン(又はN-アセチル-L-シス
テイン)及び亜硫酸塩を添加する方法では、約10日間保
存時の安定化効果が認められているに過ぎず、また、亜
硫酸塩を単独で用いた場合にはアスコルビン酸の安定化
効果は認められない。As a method for stabilizing a solution containing ascorbic acid, a method in which a cyclic trimetaphosphate coexists (Japanese Patent Publication No. 59-32468), dl-N-acetylhomocysteine thiolactone (or N-acetyl-L-cysteine). ) And a method of adding a sulfite (JP-A-49-92219). Although these methods certainly have an effect of stabilizing the ascorbic acid solution, the method using coexisting cyclic trimetaphosphate has a residual ratio of ascorbic acid of only about 80% after standing at room temperature for 4 weeks. In addition, in the method of adding dl-N-acetylhomocysteine thiolactone (or N-acetyl-L-cysteine) and sulfite, only a stabilizing effect upon storage for about 10 days is recognized, When sulfite alone is used, no stabilizing effect of ascorbic acid is observed.
【0006】一方食品等の分野に於ては、フマル酸を添
加する方法(特開平4-352776)等があるが、該方法は、
アスコルビン酸を含有する飲食品の褐変化による外観の
劣悪化や風味の改善を目的としたものであり、長期間保
存後のアスコルビン酸自体の残存率を高めることを目的
としたものではない。即ち、該方法によれば、アスコル
ビン酸及びフマル酸を添加した飲料を瓶に充填、密封し
た状態で2週間(55℃)保存した場合に飲料の褐変化が
防止できたに過ぎない。従って、アスコルビン酸を含有
する溶液のより効果的な安定化方法の開発が望まれてい
る現状にある。On the other hand, in the field of foods and the like, there is a method of adding fumaric acid (JP-A-4-352776).
The purpose is to improve the appearance and the flavor of the food and drink containing ascorbic acid due to browning, and not to increase the residual ratio of ascorbic acid itself after long-term storage. That is, according to the method, when the beverage containing ascorbic acid and fumaric acid is filled in a bottle and stored in a sealed state for 2 weeks (55 ° C.), the browning of the beverage can be prevented only. Therefore, the development of a more effective method for stabilizing a solution containing ascorbic acid has been desired.
【0007】[0007]
【発明の目的】本発明は上記した如き状況に鑑みなされ
たもので、アスコルビン酸又は/及びその塩を含む溶液
の効果的な安定化方法と、該安定化されたアスコルビン
酸又は/及びその塩を含む溶液を還元剤溶液として用い
た被検試料中の鉄又は不飽和鉄結合能(UIBC)の測
定方法を提供することを目的とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and provides an effective method for stabilizing a solution containing ascorbic acid or / and a salt thereof; It is an object of the present invention to provide a method for measuring iron or unsaturated iron binding ability (UIBC) in a test sample, using a solution containing as a reducing agent solution.
【0008】[0008]
【問題を解決するための手段】本発明は、アスコルビン
酸又は/及びその塩を含む溶液に、ピロ亜硫酸塩を共存
させることを特徴とする、該溶液の安定化方法である。
また、本発明は、その溶液中にピロ亜硫酸塩を共存させ
たことを特徴とする、アスコルビン酸又は/及びその塩
を含む溶液(但し、下記一般式[I]で示されるアミノケ
トン誘導体が含有される場合を除く。)SUMMARY OF THE INVENTION The present invention is a method for stabilizing a solution containing ascorbic acid or / and a salt thereof, wherein pyrosulfite is present in the solution.
Further, the present invention provides a solution containing ascorbic acid or / and a salt thereof (provided that an aminoketone derivative represented by the following general formula [I] is contained), characterized in that pyrosulfite coexists in the solution. Excluding cases where
【化2】 (式中、R1は水素原子又はC1〜4アルキル基を表わ
し、R2はパラ位置においてC1〜10アルキル基により置
換されたフェニル基を表わし、あるいはR1及びR2は一
緒にC3〜5アルキレン基を形成するものであってもよ
く、Xは一価のアニオン又は1等量の多価アニオンを表
わす。)の発明である。更に、本発明は三価の鉄の還元
剤としてアスコルビン酸又は/及びその塩を用いる鉄又
はUIBCの測定方法に於て、アスコルビン酸又は/及
びその塩を含む溶液にピロ亜硫酸塩を共存させて成る溶
液を還元剤溶液として用いることを特徴とする、被検試
料中の鉄又はUIBCの測定方法の発明である。即ち、
本発明者等は、アスコルビン酸又は/及びその塩を含む
溶液の安定化方法について鋭意研究の途上、ピロ亜硫酸
塩に、意外にもアスコルビン酸又は/及びその塩を含む
溶液の安定化効果があることを見出し、本発明を完成さ
せるに到った。Embedded image (Wherein, R 1 represents a hydrogen atom or a C 1 ~ 4 alkyl group, R 2 represents a phenyl group substituted by C 1 ~ 10 alkyl group in the para position, or R 1 and R 2 are C together X may form a 3 to 5 alkylene group, and X represents a monovalent anion or one equivalent of a polyvalent anion.) Further, the present invention relates to a method for measuring iron or UIBC using ascorbic acid or / and its salt as a reducing agent for trivalent iron, wherein pyrosulfite is added to a solution containing ascorbic acid or / and its salt. A method for measuring iron or UIBC in a test sample, characterized by using the resulting solution as a reducing agent solution. That is,
The inventors of the present invention have intensively studied a method for stabilizing a solution containing ascorbic acid or / and a salt thereof. As a result, pyrosulfite unexpectedly has a stabilizing effect on a solution containing ascorbic acid or / and / or a salt thereof. This led to the completion of the present invention.
【0009】本発明に用いられるピロ亜硫酸の塩類とし
ては、アルカリ金属塩、アンモニウム塩、アルカリ土類
金属塩のうち、必要量が溶解できるものであれば何れも
利用できるが、市販品として手に入れ易いことから、通
常、ピロ亜硫酸ナトリウム、ピロ亜硫酸カリウムが好ま
しく使用される。ピロ亜硫酸塩の至適濃度は、pH、ア
スコルビン酸濃度等により異なるが、通常0.001w/v%以
上、好ましくは0.01w/v%以上である。また、鉄又はU
IBCの測定に於て、還元剤として用いるアスコルビン
酸の安定化剤としてピロ亜硫酸塩を共存させる場合に
は、測定系にピロ亜硫酸塩の還元作用の影響が出ない程
度の低濃度で用いることが好ましく、その場合のピロ亜
硫酸塩の濃度としては、溶液中の濃度として、0.01〜0.
5w/v%程度である。また、本発明に係るアスコルビン酸
又は/及びその塩を含む溶液のpHは、通常2〜8の範
囲、好ましくはpH2〜5の範囲である。本発明に係る
アスコルビン酸又は/及びその塩を含む溶液に於て、用
いられる溶媒は、用いる試薬類が溶解し、また最終pH
が2〜8の範囲になるものであれば何れにてもよく、例
えば蒸留水、イオン交換水、上記pH内に緩衝能を持つ
各種緩衝液等が挙げられるが、これらに限定されるもの
ではない。。As the salts of pyrosulfite used in the present invention, any of alkali metal salts, ammonium salts, and alkaline earth metal salts can be used as long as the required amount can be dissolved. Usually, sodium pyrosulfite and potassium pyrosulfite are preferably used because they are easy to put. The optimum concentration of pyrosulfite varies depending on pH, ascorbic acid concentration and the like, but is usually 0.001 w / v% or more, preferably 0.01 w / v% or more. Also, iron or U
In the measurement of IBC, when pyrosulfite is used as a stabilizer for ascorbic acid to be used as a reducing agent, it must be used at a low concentration that does not affect the effect of the reduction of pyrosulfite in the measurement system. Preferably, the concentration of pyrosulfite in that case is 0.01 to 0.
It is about 5w / v%. The pH of the solution containing ascorbic acid and / or a salt thereof according to the present invention is usually in the range of 2 to 8, preferably in the range of 2 to 5. In the solution containing ascorbic acid and / or a salt thereof according to the present invention, the solvent used is such that the reagents used are dissolved and the final pH
May be any one as long as it falls within the range of 2 to 8, and examples thereof include distilled water, ion-exchanged water, and various buffers having a buffering capacity within the above pH, but are not limited thereto. Absent. .
【0010】本発明を実施するには、本発明に係る安定
化剤であるピロ亜硫酸塩をアスコルビン酸又は/及びそ
の塩を含む溶液中に共存させるだけでよく、何等特別な
操作は不要である。本発明に係るアスコルビン酸又は/
及びその塩を含む溶液中には、安定化剤としてのピロ亜
硫酸塩の他に、必要に応じて各種防腐剤、緩衝剤、界面
活性剤その他の薬品類が共存していても構わない(但
し、アスコルビン酸又は/及びその塩やピロ亜硫酸塩に
対して反応性を有する物質の共存は不可であることは言
うまでもない。)。また、アスコルビン酸又は/及びそ
の塩を含む溶液にピロ亜硫酸塩を共存させて成る溶液を
還元剤溶液として用いる本発明に係る鉄又はUIBCの
測定方法に於て、該還元剤溶液以外に用いられる発色試
薬、緩衝剤、各種防腐剤、界面活性剤、その他の試薬類
等は、アスコルビン酸又は/及びその塩を含む溶液を還
元剤溶液として用いる、自体公知の鉄又はUIBCの測
定方法に於て用いられる試薬類等が全てそのまま使用可
能であり、またそれら試薬類等の濃度範囲等も、自体公
知の該測定法に於て通常用いられる濃度範囲等を適宜選
択して用いることで足りる。また、測定操作等も、本発
明に係るアスコルビン酸又は/及びその塩を含む溶液を
使用する以外は、自体公知の鉄又はUIBCの測定方法
に準じてこれを行うことで足りる。In order to carry out the present invention, pyrosulfite as a stabilizer according to the present invention only needs to coexist in a solution containing ascorbic acid and / or a salt thereof, and no special operation is required. . Ascorbic acid according to the present invention or /
And a solution containing a salt thereof, if necessary, in addition to pyrosulfite as a stabilizing agent, various preservatives, buffers, surfactants and other chemicals may coexist (but not necessarily Needless to say, a substance having reactivity with ascorbic acid and / or its salt or pyrosulfite cannot be present.) Further, in the method for measuring iron or UIBC according to the present invention, in which a solution containing ascorbic acid and / or a salt thereof and coexisting pyrosulfite is used as the reducing agent solution, a solution other than the reducing agent solution is used. Coloring reagents, buffers, various preservatives, surfactants, and other reagents are used in the per se known method of measuring iron or UIBC using a solution containing ascorbic acid or / and its salt as a reducing agent solution. All the reagents and the like to be used can be used as they are, and the concentration range and the like of the reagents and the like can be determined by appropriately selecting a concentration range and the like usually used in the measurement method known per se. In addition, the measurement operation and the like may be performed according to a method for measuring iron or UIBC known per se, except that the solution containing ascorbic acid or / and a salt thereof according to the present invention is used.
【0011】本発明に係る安定化方法は、アスコルビン
酸を用いる各種分野、例えば臨床診断薬、健康医薬品、
機能性食品、化粧品、その他多方面で幅広く利用でき
る。また、本発明に係る鉄の測定方法は、臨床検査の分
野だけでなく、水質検査、その他多方面に於て、幅広く
利用できる。これまで、ピロ亜硫酸塩が鉄やUIBCの
測定用試薬に於ける還元剤として用いられた例はある
が、これがアスコルビン酸又は/及びその塩を含む溶液
の安定化に極めて有効であり、アスコルビン酸又は/及
びその塩を含む溶液を還元剤溶液として用いる鉄又はU
IBCの測定方法に於て、還元剤溶液の安定化に有効に
使用し得るということは、全く意外なことであった。
尚、本発明に係る鉄又はUIBCの測定方法は、用手法
に限らず、自動分析装置を用いた測定系にも利用でき
る。[0011] The stabilization method according to the present invention can be applied to various fields using ascorbic acid, such as clinical diagnostics, health pharmaceuticals
It can be widely used in functional foods, cosmetics, and other fields. Further, the method for measuring iron according to the present invention can be widely used not only in the field of clinical examination, but also in water quality examination and other various fields. Heretofore, there has been an example in which pyrosulfite has been used as a reducing agent in a reagent for measuring iron or UIBC, but this is extremely effective in stabilizing a solution containing ascorbic acid or / and a salt thereof. Or / and / or using a solution containing a salt thereof as a reducing agent solution
It was completely surprising that the method of measuring IBC can be effectively used for stabilizing a reducing agent solution.
The method for measuring iron or UIBC according to the present invention is not limited to the method used, but can be used for a measurement system using an automatic analyzer.
【0012】[0012]
【実施例】 実施例1. [アスコルビン酸溶液の調製]0.4Mグリシン緩衝液にア
スコルビン酸を0.4%,ピロ亜硫酸ナトリウムを0.1%の
濃度になるように溶解し、塩酸又は水酸化カリウムでp
Hを2.0〜8.0に調整した。 [保存条件]調製したアスコルビン酸溶液を25℃のイン
キュベーターに保存した。 [アスコルビン酸濃度の測定]調製直後、1ヶ月保存後
及び3ヶ月保存後のアスコルビン酸溶液の夫々につい
て、下記の方法でアスコルビン酸濃度を測定した。ま
ず、リン酸一アンモニウムが15g/dl(1.3M/l)、メタノ
ールが7.5ml/dl、アセチルアセトンが0.15ml/dl、カタ
ラーゼが45,000U/dl、硫酸銅(II)五水和物が2.5mg/dl
(0.1mM/l)になるようにこれらをイオン交換水に溶解
し、水酸化ナトリウムでpHを7.0に調整して発色試液と
した。各アスコルビン酸溶液夫々100μlをとり、上記発
色試液4.0mlを加え37℃恒温槽中で60分間加温反応後、
試薬ブランクを対照として410nmの吸光度を測定した。
濃度既知のアスコルビン酸を含有する標準液(10,20,
30,50,80,100mg/dl)100μlをとり、同様の操作を行
って吸光度を測定し、アスコルビン酸標準液の濃度と吸
光度から検量線を作成した。この検量線からアスコルビ
ン酸溶液中のアスコルビン酸濃度を算出した。調製直後
のアスコルビン酸濃度を100%とし、1ヶ月保存後及び
3ヶ月保存後のアスコルビン酸溶液中のアスコルビン酸
濃度の残存率を求めた。結果を表1に示す。Embodiment 1 [Preparation of ascorbic acid solution] Dissolve ascorbic acid to a concentration of 0.4% and sodium pyrosulfite to a concentration of 0.1% in a 0.4 M glycine buffer, and add hydrochloric acid or potassium hydroxide to the solution.
H was adjusted to 2.0-8.0. [Storage conditions] The prepared ascorbic acid solution was stored in an incubator at 25 ° C. [Measurement of Ascorbic Acid Concentration] Immediately after preparation, the ascorbic acid concentration of each of the ascorbic acid solutions after storage for one month and after storage for three months was measured by the following method. First, monoammonium phosphate is 15 g / dl (1.3 M / l), methanol is 7.5 ml / dl, acetylacetone is 0.15 ml / dl, catalase is 45,000 U / dl, and copper (II) sulfate pentahydrate is 2.5 mg. / dl
(0.1 mM / l) were dissolved in ion-exchanged water, and the pH was adjusted to 7.0 with sodium hydroxide to prepare a color reagent solution. Take 100 μl of each ascorbic acid solution, add 4.0 ml of the above coloring reagent solution, and heat up for 60 minutes in a 37 ° C constant temperature bath.
The absorbance at 410 nm was measured using the reagent blank as a control.
Standard solutions containing ascorbic acid of known concentration (10, 20,
A 100 μl portion of 30, 50, 80, 100 mg / dl) was taken, the absorbance was measured in the same manner, and a calibration curve was prepared from the concentration and the absorbance of the ascorbic acid standard solution. From this calibration curve, the ascorbic acid concentration in the ascorbic acid solution was calculated. With the ascorbic acid concentration immediately after preparation as 100%, the residual ratio of the ascorbic acid concentration in the ascorbic acid solution after storage for 1 month and after storage for 3 months was determined. Table 1 shows the results.
【0013】比較例1.0.4Mグリシン緩衝液にアスコル
ビン酸を0.4%の濃度になるように溶解し、塩酸又は水
酸化カリウムでpHを2.0〜8.0に調整した。その後、実
施例1と同様に保存し、調製直後のアスコルビン酸濃度
を100%とし、1ヶ月保存後及び3ヶ月保存後のアスコ
ルビン酸溶液中のアスコルビン酸濃度の残存率を実施例
1と同様の方法で求めた。結果を表1に併せて示す。Comparative Example 1. Ascorbic acid was dissolved in 0.4M glycine buffer to a concentration of 0.4%, and the pH was adjusted to 2.0 to 8.0 with hydrochloric acid or potassium hydroxide. After that, it was stored in the same manner as in Example 1, and the ascorbic acid concentration immediately after the preparation was set to 100%. The residual ratio of the ascorbic acid concentration in the ascorbic acid solution after storage for 1 month and after storage for 3 months was the same as in Example 1. Asked by the way. The results are shown in Table 1.
【0014】[0014]
【表1】 [Table 1]
【0015】表1の結果から明らかな如く、ピロ亜硫酸
ナトリウムをアスコルビン酸溶液中に共存させると、ア
スコルビン酸の溶液中の残存率が著しく向上し、特にp
H2〜5に於ては3ヶ月保存後でも調製直後と比べて殆
ど変化していないことが判る。As is clear from the results in Table 1, when sodium pyrosulfite coexists in the ascorbic acid solution, the residual ratio of ascorbic acid in the solution is remarkably improved.
It can be seen that in H2 to H5, even after storage for 3 months, there was almost no change compared to immediately after preparation.
【0016】実施例2. [アスコルビン酸溶液の調製]0.4Mグリシン緩衝液にア
スコルビン酸を0.4%、ピロ亜硫酸ナトリウムを0.001〜
1%の濃度になるように溶解し、塩酸でpH3.0に調整し
た。 [保存条件]調製したアスコルビン酸溶液を25℃のイン
キュベーターに保存した。 [アスコルビン酸濃度の測定]調製直後、10日間保存後
及び30日間保存後のアスコルビン酸溶液の夫々につい
て、実施例1と同様の方法でアスコルビン酸濃度を測定
した。調製直後のアスコルビン酸濃度を100%とし、10
日間保存後及び30日間保存後のアスコルビン酸溶液中の
アスコルビン酸濃度の残存率を実施例1と同様の方法で
求めた。結果を表2に示す。Embodiment 2 FIG. [Preparation of ascorbic acid solution] 0.4M glycine buffer contains 0.4% of ascorbic acid and 0.001% of sodium pyrosulfite.
It was dissolved to a concentration of 1% and adjusted to pH 3.0 with hydrochloric acid. [Storage conditions] The prepared ascorbic acid solution was stored in an incubator at 25 ° C. [Measurement of Ascorbic Acid Concentration] Immediately after the preparation, the ascorbic acid solution was measured in the same manner as in Example 1 for each of the ascorbic acid solutions after storage for 10 days and after storage for 30 days. The ascorbic acid concentration immediately after preparation is 100%,
The residual ratio of ascorbic acid concentration in the ascorbic acid solution after storage for 30 days and after storage for 30 days was determined in the same manner as in Example 1. Table 2 shows the results.
【0017】比較例2.0.4Mグリシン緩衝液にアスコル
ビン酸を0.4%の濃度になるように溶解し、塩酸でpH3.
0に調整した。その後、実施例2と同様に保存し、調製
直後のアスコルビン酸濃度を100%とし、10日間保存後
及び30日間保存後のアスコルビン酸溶液中のアスコルビ
ン酸濃度の残存率を実施例1と同様の方法で求めた。結
果を表2に併せて示す。Comparative Example 2. Ascorbic acid was dissolved in a 0.4 M glycine buffer to a concentration of 0.4%, and the pH was adjusted to pH 3 with hydrochloric acid.
Adjusted to 0. Then, it was stored in the same manner as in Example 2. The ascorbic acid concentration immediately after the preparation was set to 100%, and the residual ratio of the ascorbic acid concentration in the ascorbic acid solution after storage for 10 days and after storage for 30 days was the same as in Example 1. Asked by the way. The results are shown in Table 2.
【0018】[0018]
【表2】 [Table 2]
【0019】表2の結果からも明らかな如く、ピロ亜硫
酸ナトリウムをアスコルビン酸溶液中に共存させると、
アスコルビン酸の溶液中の残存率が著しく向上し、特に
ピロ亜硫酸ナトリウムの濃度が0.01%以上になると、30
日保存後でも極めて安定であることが判る。As is clear from the results in Table 2, when sodium pyrosulfite coexists in the ascorbic acid solution,
The residual ratio of ascorbic acid in the solution is significantly improved, especially when the concentration of sodium pyrosulfite becomes 0.01% or more.
It turns out that it is extremely stable even after storage for days.
【0020】実施例3 血清鉄の測定 [アスコルビン酸溶液の調製]0.4Mグリシン緩衝液にア
スコルビン酸を0.4%、ピロ亜硫酸ナトリウムを0.1%、
トリトンX-100(化学名:ポリオキシエチレン(10)オク
チルフェニルエーテル、ローム アンド ハース社商品
名)を0.7%の濃度になるように溶解し、塩酸でpH3.0
に調整した。 [発色液の調製]0.1Mグリシン緩衝液にバソフェナン
トロリンスルホン酸ナトリウムを0.1%の濃度になるよ
うに溶解し、塩酸でpH3.0に調整した。 [血清鉄の測定方法]血清試料20μlに上で調製したア
スコルビン酸溶液300μlを加え、37℃で5分間加温した
後、発色液75μlを加え、更に5分間加温後、主波長546
nm、副波長600nmの二波長吸光度を測定した。試料の代
わりに蒸留水を用いて同様に測定を行った結果を試薬盲
検とした。また、試料の代わりに標準液(鉄200μg/d
l)を用いて同様に測定を行った。下記の式1より血清
鉄濃度を算出した。Example 3 Measurement of serum iron [Preparation of ascorbic acid solution] In a 0.4M glycine buffer, ascorbic acid was 0.4%, sodium pyrosulfite was 0.1%,
Triton X-100 (chemical name: polyoxyethylene (10) octyl phenyl ether, trade name of Rohm and Haas Company) is dissolved to a concentration of 0.7%, and the pH is adjusted to 3.0 with hydrochloric acid.
Was adjusted. [Preparation of Coloring Solution] In a 0.1 M glycine buffer, sodium bathophenanthroline sulfonate was dissolved to a concentration of 0.1%, and the pH was adjusted to 3.0 with hydrochloric acid. [Measurement method of serum iron] 300 μl of the ascorbic acid solution prepared above was added to 20 μl of a serum sample, heated at 37 ° C. for 5 minutes, 75 μl of a coloring solution was added, and after further heating for 5 minutes, the main wavelength was 546.
The two-wavelength absorbance at 600 nm and the auxiliary wavelength of 600 nm was measured. The same measurement was performed using distilled water instead of the sample, and the result was regarded as a reagent blind. In addition, instead of the sample, use a standard solution (iron 200μg / d
The measurement was similarly performed using l). The serum iron concentration was calculated from the following equation 1.
【式1】 結果を表3に示す。(Equation 1) Table 3 shows the results.
【0021】比較例3 還元剤としてチオグリコール酸を用い、発色試液として
2-ニトロソ-5-(N-プロピル-N-スルホプロピル)アミノフ
ェノール(Nitroso-PSAP)を用いた血清鉄測定用市販キ
ットであるFe C-テストワコー(和光純薬工業(株)製)
を用い、実施例3と同じ血清試料について、下記の方法
で血清鉄の濃度を測定した。0.4M酢酸緩衝液(pH6.2
5、界面活性剤,還元剤チオグリコール酸を含有する)
を2.0ml、試料0.2mlを混合し、次いで発色試液(Nitros
o-PSAP)を1滴加え、良く混合し、室温で5分間放置
後、試薬盲検を対照として750nmでの吸光度を測定し
た。血清試料の代わりに蒸留水を用いて同様に測定を行
った結果を試薬盲検とした。また、血清試料の代わりに
鉄標準液(鉄200μg/dl)を用いて同様に測定を行っ
た。式1から、試料中の血清鉄の濃度を算出した。結果
を表3に併せて示す。Comparative Example 3 Using thioglycolic acid as a reducing agent and a color reagent
Fe C-Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.), a commercial kit for serum iron measurement using 2-nitroso-5- (N-propyl-N-sulfopropyl) aminophenol (Nitroso-PSAP)
The serum iron concentration of the same serum sample as in Example 3 was measured by the following method. 0.4 M acetate buffer (pH 6.2
5, contains surfactant and reducing agent thioglycolic acid)
And 2.0 ml of the sample were mixed, and then a color reagent (Nitros
o-PSAP) was added thereto, mixed well, and allowed to stand at room temperature for 5 minutes. Then, the absorbance at 750 nm was measured using a reagent blank as a control. The same measurement was performed using distilled water in place of the serum sample, and the result was regarded as reagent blind. In addition, the same measurement was performed using an iron standard solution (iron 200 μg / dl) instead of the serum sample. From Equation 1, the concentration of serum iron in the sample was calculated. The results are shown in Table 3.
【0022】[0022]
【表3】 [Table 3]
【0023】表3の結果から明らかな如く、本発明に係
るピロ亜硫酸ナトリウムを共存させたアスコルビン酸溶
液を還元剤溶液として用いて血清鉄の測定を行った場合
と従来の血清鉄測定用の試薬を用いて測定を行った場合
とを比較すると、測定値に差が見られず、ピロ亜硫酸塩
を測定系に添加しても、血清鉄の測定値への影響がない
ことが判る。As is clear from the results shown in Table 3, serum iron was measured using the ascorbic acid solution containing sodium pyrosulfite according to the present invention as a reducing agent solution, and a conventional reagent for measuring serum iron. When compared with the case where the measurement was carried out using, there is no difference in the measured values, and it can be seen that the addition of pyrosulfite to the measurement system does not affect the measured value of serum iron.
【0024】 実施例4.血清不飽和鉄結合能(UIBC)の測定 [緩衝液の調製]0.4Mグリシン緩衝液(pH8.6)に硫
酸第一鉄アンモニウムを、鉄として80μg/dlの濃度にな
るように溶解した。 [アスコルビン酸溶液の調製]蒸留水にアスコルビン酸
を0.5%、ピロ亜硫酸ナトリウムを0.1%、バソフェナン
トロリンスルホン酸ナトリウムを0.1%の濃度になるよ
うに溶解し、pH3.0に調整した。 [UIBCの測定方法]試料20μlに上記緩衝液300μl
を加え、37℃で5分間加温した後、上記アスコルビン酸
溶液75μlを加え、更に5分間加温後、主波長546nm、副
波長600nmの二波長吸光度を測定した。同様に試薬盲検
を測定し、鉄の減少量から、UIBCを求めた。結果を
表4に示す。Embodiment 4 Measurement of serum unsaturated iron binding ability (UIBC) [Preparation of buffer solution] Ammonium ferrous sulfate was dissolved in a 0.4 M glycine buffer solution (pH 8.6) to a concentration of 80 µg / dl as iron. [Preparation of ascorbic acid solution] Ascorbic acid was dissolved in distilled water to a concentration of 0.5%, sodium pyrosulfite to 0.1%, and sodium bathophenanthroline sulfonate to a concentration of 0.1%, and the pH was adjusted to 3.0. [Measurement method of UIBC] 300 µl of the above buffer solution was added to 20 µl of the sample.
After heating at 37 ° C. for 5 minutes, 75 μl of the above ascorbic acid solution was added, and after further heating for 5 minutes, two-wavelength absorbance at a main wavelength of 546 nm and a sub-wavelength of 600 nm was measured. Similarly, reagent blinding was measured, and UIBC was determined from the amount of reduced iron. Table 4 shows the results.
【0025】比較例4. 還元剤としてメタ重亜硫酸ナトリウム(ピロ亜硫酸ナト
リウム)を用い、発色試薬として2-ニトロソ-5-(N-プロ
ピル-N-スルホプロピル)アミノフェノール(Nitroso-PS
AP)を用いた不飽和鉄結合能測定用試薬キットであるUI
BC-テストワコー(和光純薬工業(株)製)を用い、実施
例4と同じ血清について下記の方法でUIBCを測定し
た。使用緩衝液(0.16M トリス緩衝液 pH8.6、還元剤
メタ重亜硫酸ナトリウム,硫酸第一鉄アンモニウムをF
e2+として 100μg/dlを含む。)2.0mlと血清試料0.2ml
とを混合し、室温で30分間放置した。次いで発色試液
(Nitroso-PSAP)を1滴加えて良く混合し、室温で15分
間放置後、蒸留水を対照にして750nmでの吸光度を測定
した。血清試料の代わりに蒸留水を用いて同様に測定を
行い試薬盲検とした。UIBCは、下記式により算出し
た。Comparative Example 4 Using sodium metabisulfite (sodium pyrosulfite) as a reducing agent and 2-nitroso-5- (N-propyl-N-sulfopropyl) aminophenol (Nitroso-PS) as a coloring reagent
UI, a reagent kit for measuring unsaturated iron binding ability using AP)
Using BC-Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.), UIBC was measured for the same serum as in Example 4 by the following method. Buffer used (0.16M Tris buffer pH 8.6, reducing agent sodium metabisulfite, ammonium ferrous sulfate
Contains 100 μg / dl as e 2+ . ) 2.0ml and serum sample 0.2ml
And left at room temperature for 30 minutes. Next, one drop of a color reagent solution (Nitroso-PSAP) was added and mixed well, and the mixture was allowed to stand at room temperature for 15 minutes, and the absorbance at 750 nm was measured using distilled water as a control. The measurement was similarly performed using distilled water instead of the serum sample, and the reagent was blinded. UIBC was calculated by the following equation.
【式2】 結果を表4に併せて示す。(Equation 2) The results are shown in Table 4.
【0026】[0026]
【表4】 [Table 4]
【0027】表4の結果から明らかな如く、本発明に係
るピロ亜硫酸ナトリウムを共存させたアスコルビン酸溶
液を還元剤溶液として用いてUIBCの測定を行った場
合と従来のUIBC測定用の試薬を用いて測定を行った
場合とを比較すると、測定値に差が見られず、ピロ亜硫
酸塩を測定系に添加しても、UIBCの測定値への影響
がないことが判る。As is clear from the results in Table 4, UIBC was measured using an ascorbic acid solution containing sodium pyrosulfite according to the present invention as a reducing agent solution, and a conventional reagent for UIBC measurement was used. In comparison with the case where the measurement was carried out, no difference was observed in the measured values, and it was found that addition of pyrosulfite to the measurement system did not affect the measured values of UIBC.
【0028】実施例5.血清鉄の測定 [アスコルビン酸溶液の調製]0.4Mグリシン緩衝液にア
スコルビン酸を0.4%、ピロ亜硫酸ナトリウムを0.1%、
トリトンX-100(化学名:ポリオキシエチレン(10)オク
チルフェニルエーテル、ローム アンド ハース社商品
名)を0.7%の濃度になるように溶解し、塩酸でpH3.0
に調整した。調製後、25℃インキュベーターで3ヶ月保
存した。 [発色液の調製]0.1Mグリシン緩衝液にバソフェナン
トロリンスルホン酸ナトリウムを0.1%の濃度になるよ
うに溶解し、塩酸でpH3.0に調整した。 [血清鉄の測定方法]調製直後及び3ヶ月保存後の上記
アスコルビン酸溶液を用い、実施例3の方法に従って、
夫々血清鉄の測定を行った。結果を表5に示す。Embodiment 5 FIG. Measurement of serum iron [Preparation of ascorbic acid solution] 0.4% ascorbic acid, 0.1% sodium pyrosulfite in 0.4M glycine buffer,
Triton X-100 (chemical name: polyoxyethylene (10) octyl phenyl ether, trade name of Rohm and Haas Company) is dissolved to a concentration of 0.7%, and the pH is adjusted to 3.0 with hydrochloric acid.
Was adjusted. After the preparation, it was stored in a 25 ° C. incubator for 3 months. [Preparation of Coloring Solution] In a 0.1 M glycine buffer, sodium bathophenanthroline sulfonate was dissolved to a concentration of 0.1%, and the pH was adjusted to 3.0 with hydrochloric acid. [Measurement method of serum iron] Using the above ascorbic acid solution immediately after preparation and after storage for 3 months, according to the method of Example 3,
Each was measured for serum iron. Table 5 shows the results.
【0029】比較例5 [アスコルビン酸溶液の調製]0.4Mグリシン緩衝液にア
スコルビン酸を0.4%、トリトンX-100を0.7%の濃度に
なるように溶解し、塩酸でpH3.0に調整した。調製後、
25℃インキュベーターで3ヶ月保存した。 [血清鉄の測定方法]調製直後及び3ヶ月保存後の上記
アスコルビン酸溶液を用い、実施例5と同じ血清につい
て実施例3の方法に従って夫々血清鉄の測定を行った。
結果を表5に併せて示す。 比較例6 Fe C-テストワコー(和光純薬工業(株)製)を用い、実
施例5と同じ血清について比較例3と同様の方法で血清
鉄の測定を行った。結果を表5に併せて示す。Comparative Example 5 [Preparation of Ascorbic Acid Solution] Ascorbic acid was dissolved to a concentration of 0.4% and Triton X-100 to a concentration of 0.7% in a 0.4 M glycine buffer, and the pH was adjusted to 3.0 with hydrochloric acid. After preparation
It was stored for 3 months in a 25 ° C. incubator. [Measurement Method of Serum Iron] Serum iron was measured according to the method of Example 3 for the same serum as in Example 5 using the above ascorbic acid solution immediately after preparation and after storage for 3 months.
The results are shown in Table 5. Comparative Example 6 Using Fe C-Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.), serum iron was measured in the same manner as in Example 5 in the same manner as in Comparative Example 3. The results are shown in Table 5.
【0030】[0030]
【表5】 [Table 5]
【0031】表5の結果から明らかな如く、ピロ亜硫酸
ナトリウムを添加しなかった比較例5では、3ヶ月保存
したアスコルビン酸を用いた場合、全般に測定値が高く
測定される傾向がみられたが、ピロ亜硫酸ナトリウムを
添加した実施例5では、調製直後と25℃、3ヶ月保存後
のアスコルビン酸を用いた場合での測定値には差が見ら
れなかった。また、本発明の方法(実施例5)と従来の
試薬を用いた場合(比較例6)とを比較すると、本発明
の方法により調製したアスコルビン酸溶液を用いると、
3ヶ月保存後の溶液を用いた場合でも、測定値への影響
がなく、血清鉄測定用試薬として充分使用可能であるこ
とが判る。As is clear from the results in Table 5, in Comparative Example 5 in which sodium pyrosulfite was not added, when ascorbic acid stored for 3 months was used, the measured values generally tended to be higher. However, in Example 5 to which sodium pyrosulfite was added, there was no difference between the measured values immediately after preparation and the values measured using ascorbic acid after storage at 25 ° C. for 3 months. Also, comparing the method of the present invention (Example 5) with the case of using the conventional reagent (Comparative Example 6), the ascorbic acid solution prepared by the method of the present invention shows that
Even when the solution after storage for 3 months was used, there was no effect on the measured values, indicating that the solution was sufficiently usable as a reagent for measuring serum iron.
【0032】[0032]
【発明の効果】本発明は、アスコルビン酸又は/及びそ
の塩を含む溶液の効果的な安定化方法を提供するもので
あり、本発明の方法によれば、従来不安定で安定化する
ことが難しかったアスコルビン酸又は/及びその塩を含
む溶液を長期間安定に保存することがてきる点、及び当
該安定化方法は、三価の鉄の還元剤としてアスコルビン
酸又は/及びその塩を用いる鉄測定試薬やUIBC測定
試薬に於ける還元剤溶液の安定化にも充分適用可能であ
る点に顕著な効果を奏するものである。The present invention provides a method for effectively stabilizing a solution containing ascorbic acid and / or a salt thereof. According to the method of the present invention, the conventional method is unstable and can be stabilized. It is difficult to stably store a solution containing ascorbic acid or / and its salt for a long period of time, and the stabilization method is to use ascorbic acid or / and / or its salt as a trivalent iron reducing agent. The present invention has a remarkable effect in that it is sufficiently applicable to stabilization of a reducing agent solution in a measurement reagent or a UIBC measurement reagent.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 31/375 A61K 9/08 A61K 47/02 G01N 33/90 CA(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int.Cl. 7 , DB name) A61K 31/375 A61K 9/08 A61K 47/02 G01N 33/90 CA (STN)
Claims (10)
液に、ピロ亜硫酸塩を共存させることを特徴とする、該
溶液の安定化方法。1. A method for stabilizing a solution containing ascorbic acid or / and a salt thereof, wherein pyrosulfite is coexistent with the solution.
塩、アンモニウム塩、又はアルカリ土類金属塩である、
請求項1に記載の安定化方法。2. The pyrosulfite is an alkali metal, ammonium, or alkaline earth metal salt of pyrosulfite.
A method according to claim 1.
ピロ亜硫酸カリウムである、請求項1に記載の安定化方
法。3. The method according to claim 1, wherein the pyrosulfite is sodium or potassium pyrosulfite.
とを特徴とする、アスコルビン酸又は/及びその塩を含
む溶液(但し、下記一般式[I]で示されるアミノケトン
誘導体が含有される場合を除く。) 【化1】 (式中、R1は水素原子又はC1〜4アルキル基を表わ
し、R2はパラ位置においてC1〜10アルキル基により置
換されたフェニル基を表わし、あるいはR1及びR2は一
緒にC3〜5アルキレン基を形成するものであってもよ
く、Xは一価のアニオン又は1等量の多価アニオンを表
わす。)。4. A solution containing ascorbic acid or / and a salt thereof, wherein a solution containing an aminoketone derivative represented by the following general formula [I] is provided, wherein a pyrosulfite is coexisted in the solution. Except for the case.) (Wherein, R 1 represents a hydrogen atom or a C 1 ~ 4 alkyl group, R 2 represents a phenyl group substituted by C 1 ~ 10 alkyl group in the para position, or R 1 and R 2 are C together It may form a 3 to 5 alkylene group, and X represents a monovalent anion or one equivalent of a polyvalent anion.).
塩、アンモニウム塩、又はアルカリ土類金属塩である、
請求項4に記載の溶液。5. The pyrosulfite is an alkali metal, ammonium or alkaline earth metal salt of pyrosulfite.
The solution according to claim 4.
ピロ亜硫酸カリウムである、請求項4に記載の溶液。6. The solution according to claim 4, wherein the pyrosulfite is sodium or potassium pyrosulfite.
は/及びその塩を用いる鉄又は不飽和鉄結合能の測定方
法に於て、アスコルビン酸又は/及びその塩を含む溶液
にピロ亜硫酸塩を共存させて成る溶液を還元剤溶液とし
て用いることを特徴とする、被検試料中の鉄又は不飽和
鉄結合能の測定方法。7. A method for measuring iron or unsaturated iron binding ability using ascorbic acid or / and a salt thereof as a reducing agent for trivalent iron, wherein a solution containing ascorbic acid or / and a salt thereof contains pyrosulfite. A method for measuring the binding ability of iron or unsaturated iron in a test sample, wherein a solution prepared by coexisting is used as a reducing agent solution.
液に、ピロ亜硫酸塩を0.01〜0.5w/v%の濃度で共存させ
る、請求項7に記載の測定方法8. The method according to claim 7, wherein the solution containing ascorbic acid and / or a salt thereof is co-existed with pyrosulfite at a concentration of 0.01 to 0.5 w / v%.
塩、アンモニウム塩、又はアルカリ土類金属塩である、
請求項7又は8に記載の測定方法。9. The pyrosulfite salt is an alkali metal, ammonium or alkaline earth metal salt of pyrosulfite.
The measurement method according to claim 7.
はピロ亜硫酸カリウムである、請求項7又は8に記載の
測定方法。10. The method according to claim 7, wherein the pyrosulfite is sodium pyrosulfite or potassium pyrosulfite.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5057880A JP3008719B2 (en) | 1993-02-23 | 1993-02-23 | Method for stabilizing a solution containing ascorbic acid and / or a salt thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5057880A JP3008719B2 (en) | 1993-02-23 | 1993-02-23 | Method for stabilizing a solution containing ascorbic acid and / or a salt thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06247855A JPH06247855A (en) | 1994-09-06 |
JP3008719B2 true JP3008719B2 (en) | 2000-02-14 |
Family
ID=13068308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5057880A Expired - Fee Related JP3008719B2 (en) | 1993-02-23 | 1993-02-23 | Method for stabilizing a solution containing ascorbic acid and / or a salt thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3008719B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2767694B1 (en) * | 1997-09-02 | 1999-10-08 | Oreal | PHOSPHONIC ACID AND METABISULFITE DERIVATIVE SYSTEM FOR STABILIZING ASCORBIC ACID AND COMPOSITION CONTAINING SUCH A SYSTEM |
JP2004331524A (en) * | 2003-05-01 | 2004-11-25 | Nikko Chemical Co Ltd | Method and composition for preventing coloration and smelling of l-ascorbic acid fatty acid ester, and external preparation for skin, cosmetic and bathing agent using the method and composition |
US20070134173A1 (en) * | 2005-12-09 | 2007-06-14 | The Procter & Gamble Company | Personal care compositions |
JP5266644B2 (en) * | 2007-01-24 | 2013-08-21 | 大正製薬株式会社 | Ascorbic acid-containing liquid |
FR2968955B1 (en) * | 2010-12-15 | 2012-12-28 | Oreal | COSMETIC COMPOSITION COMPRISING ASCORBIC ACID |
DE102013018573A1 (en) | 2013-10-31 | 2015-05-21 | Stephan Teichmann | Oxidation-stable preparation |
-
1993
- 1993-02-23 JP JP5057880A patent/JP3008719B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06247855A (en) | 1994-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1881328B1 (en) | Method of determining iron concentration | |
EP2088434B1 (en) | Pyrocatechol violet-metal protein assay | |
JP3008719B2 (en) | Method for stabilizing a solution containing ascorbic acid and / or a salt thereof | |
US4588695A (en) | Determination of unsaturated iron-binding capacity | |
WO1986004610A1 (en) | Stabilized enzyme substrate solutions | |
US5151370A (en) | Reagent and method for serum iron assay | |
EP0197439B1 (en) | Method for the determination of bilirubin | |
US4382122A (en) | Calcium assay | |
JP3260020B2 (en) | UIBC measurement reagent | |
JP4224563B2 (en) | Method for stabilizing solution-state ascorbic acid or a salt thereof, a solution containing ascorbic acid or a salt thereof, and a reagent for measuring a substance to be measured in a sample | |
JPH11344490A (en) | Method for measuring iron without causing interference, and reagent | |
JP2000316600A (en) | Method for determining free fatty acid and reagent for determining free fatty acid | |
JP3839133B2 (en) | Stabilized chemiluminescent reagent | |
JP4123181B2 (en) | Calcium measuring method and measuring reagent | |
JP3170066B2 (en) | Unsaturated iron binding ability measurement reagent | |
JPH06165696A (en) | Indicator for measuring peroxide decomposing substance and reagent kit | |
JPS6035270A (en) | Prevention of hemoglobin decomposition and reagent used therefor | |
JP3719742B2 (en) | Bilirubin measuring reagent and measuring method | |
EP0335954B1 (en) | Method for forming a stable reagent for determining bilirubin in serum and reagent obtainable by said method | |
JP2002189030A (en) | Method and reagent for measurement of unsaturated iron bonding capability | |
JP2880210B2 (en) | Enzymatic method for colorimetric determination of conjugated bilirubin and reagents | |
JPH07308200A (en) | Composition for detecting and measuring activity of peroxidase-like substance and detecting and measuring oxidizing substance and measuring method therefor | |
JP2000279196A (en) | Chemiluminescence method and chemiluminescent reagent | |
JPH0599928A (en) | Reagent composition for detection of copper ion in urine | |
JPH10313895A (en) | Storage stabilizer of buffer solution and chem luminescent reagent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19991102 |
|
LAPS | Cancellation because of no payment of annual fees |